Amgen is a multinational biopharmaceutical company that produces drugs used to prevent infections in chemotherapy patients, treatment of rheumatoid arthritis, and many others.
Amgen was founded in 1983 as Applied Molecular Genetics. In 1986 the name of the company was changed to Amgen at the same time that it began trading on the NASDAQ.
In 1989 Amgen received FDA approval for Epogen, a treatment for Anemia that would prove to have wide-reaching applications for cancer and HIV patients and was the company’s first success.
In 1991 the company received approval for Neupogen for the prevention of infections in patients with compromised immune systems.
Today Amgen is the world’s largest independent biotechnology firm and uses cellular biology and medicinal chemistry to target cancers, kidney ailments, inflammatory disorders, and metabolic diseases. The company has extensive drug research and development programs.
Amgen trades publicly on the NASDAQ under the symbol AMGN, is a member of the S&P 500, has 20,000 employees, and had $18.96 billion in revenue in 2013.
AmgenAmgen is a multinational biopharmaceutical company that produces drugs used to prevent infections in chemotherapy patients, treatment of rheumatoid arthritis, and many others.
Amgen was founded in 1983 as Applied Molecular Genetics. In 1986 the name of the company was changed to Amgen at the same time that it began trading on the NASDAQ.
In 1989 Amgen received FDA approval for Epogen, a treatment for Anemia that would prove to have wide-reaching applications for cancer and HIV patients and was the company’s first success.
History
In 1991 the company received approval for Neupogen for the prevention of infections in patients with compromised immune systems.
Today Amgen is the world’s largest independent biotechnology firm and uses cellular biology and medicinal chemistry to target cancers, kidney ailments, inflammatory disorders, and metabolic diseases. The company has extensive drug research and development programs.
Amgen trades publicly on the NASDAQ under the symbol AMGN, is a member of the S&P 500, has 20,000 employees, and had $18.96 billion in revenue in 2013.
